Strategies for providing optimal care to this high-risk patient group
The immunocompromised patient population is increasing throughout the world. Major advances in transplantation techniques have expanded access to lifesaving therapies and improved outcomes in these high-risk populations. An understanding of the biology of these infections, host conditions, and the limitations of technologies used to detect and quantify such pathogens is critical to optimal care.
This new edition of
Diagnostic Microbiology of the Immunocompromised Host
covers all aspects of state-of-the-art diagnostics for infectious complications in the immunocompromised patient. Editors Randall Hayden, Karen Carroll, Yi-Wei Tang and Donna Wolk, assembled the contributions of a team of preeminent authors to discuss a broad range of topics, including
relevant aspects of host biology, antineoplastic, and transplantation techniques and the basis of immunosuppressive conditions ranging from diabetes to age-related immunosuppression
approaches, interpretations, and limitations of laboratory diagnosis of infections by a wide range of specific etiologic agents
laboratory diagnosis of infections of specific organ systems, such as respiratory tract infections, gastrointestinal tract infections, and central nervous system infections
special topics such as prosthetic devices and catheters, healthcare acquired infections, and morphologic considerations (anatomic pathology)
future diagnostic technologies and their potential impact on the field
is a resource for laboratory medicine specialists, pathologists, technologists, students, and clinical care professionals who are involved or interested in the care of the immunocompromised host.
If you are looking for online access to the latest clinical microbiology content, please visit www.wiley.com/learn/clinmicronow.